Related Experiment Videos
The morphological progression of viral myocarditis
Postgraduate Medical Journal
|June 1, 1986
Summary
Dilated cardiomyopathy may develop from acute myocarditis, even with immunosuppressive treatment. Not all myocarditis cases progress, and steroids may not prevent this progression.
Area of Science:
- Cardiology
- Pathology
Background:
- Acute myocarditis is an inflammation of the heart muscle.
- Dilated cardiomyopathy is a condition characterized by enlargement and weakening of the left ventricle.
Purpose of the Study:
- To investigate the morphological progression from acute myocarditis to dilated cardiomyopathy.
- To assess the impact of immunosuppressive treatment on this progression.
Main Methods:
- Serial endomyocardial biopsies were performed on 20 patients diagnosed with myocarditis.
- Patients' ages ranged from 6 months to 62 years, with biopsy intervals of 1 month to 2 years.
- Fifteen patients received immunosuppressive drugs; 5 did not.
Main Results:
- In all patients, inflammatory infiltrates decreased, but myocardial hypertrophy and interstitial fibrosis increased.
- Eight patients showed morphological changes consistent with dilated cardiomyopathy.
- Immunosuppressive treatment did not consistently prevent progression to dilated cardiomyopathy; some treated patients worsened, while some untreated patients stabilized spontaneously.
Conclusions:
- Dilated cardiomyopathy can be a morphological end result of acute myocarditis.
- Progression from acute myocarditis to dilated cardiomyopathy is not inevitable.
- Immunosuppressive therapy may not prevent the progression of myocarditis to dilated cardiomyopathy.